HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and COO Cortney Caudill sold $278K of Halozyme Therapeutics, Inc.
Sold$277,905
$65.19Price
4,263Shares
−25%Stake
What HALO did after the filing
- The stock from Fri, Dec 19 close, $67.35
- +15.7%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Feb 4 close.
Traded Sat, Nov 1. Filed Fri, Dec 19, 12:39 PM ET, during the session. Returns use the Dec 19 close and the Feb 4 close. Not investment advice.